Zhejiang Pharmaceutical: Guotou Gaoke plans to reduce its stake by 1% in 3 months.

Zhejiang Medicine announced that its shareholder, Guotou Gaoke Technology Investment Co., Ltd., holds 150 million shares of the company, accounting for 15.61%; it plans to reduce its holdings by no more than 9.6164 million shares, or less than 1%, through centralized competitive bidding from October 23, 2025 to January 22, 2026. The source of the reduction in holdings is from shares acquired before the IPO and its stock dividends.